Carrie M. Mosher, Ph.D.
Affiliations: | 2008 | University of Washington, Seattle, Seattle, WA |
Area:
Pharmacology, BiochemistryGoogle:
"Carrie Mosher"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Allan E. Rettie | grad student | 2008 | University of Washington | |
| (CYP2C9 binding determinants and activation mechanisms for phenytoin and (S)-warfarin metabolism.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bratton SM, Mosher CM, Khallouki F, et al. (2012) Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases. The Journal of Pharmacology and Experimental Therapeutics. 340: 46-55 |
| Mosher CM, Court MH. (2010) Comparative and veterinary pharmacogenomics. Handbook of Experimental Pharmacology. 49-77 |
| Mosher CM, Tai G, Rettie AE. (2009) CYP2C9 amino acid residues influencing phenytoin turnover and metabolite regio- and stereochemistry. The Journal of Pharmacology and Experimental Therapeutics. 329: 938-44 |
| Mosher CM, Hummel MA, Tracy TS, et al. (2008) Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9. Biochemistry. 47: 11725-34 |
| Hummel MA, Locuson CW, Gannett PM, et al. (2005) CYP2C9 genotype-dependent effects on in vitro drug-drug interactions: switching of benzbromarone effect from inhibition to activation in the CYP2C9.3 variant. Molecular Pharmacology. 68: 644-51 |